420 related articles for article (PubMed ID: 25124187)
1. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality.
Ye QF; Zhao J; Wan QQ; Qiao BB; Zhou JD
Transpl Infect Dis; 2014 Oct; 16(5):767-74. PubMed ID: 25124187
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; Roca J; Cruzado JM; Carratalà J
Transplantation; 2013 Nov; 96(9):843-9. PubMed ID: 23883973
[TBL] [Abstract][Full Text] [Related]
3. The risk factors for mortality and septic shock in liver transplant recipients with ESKAPE bacteremia.
Ouyang W; Li X; Wan Q; Ye Q
Hepatogastroenterology; 2015; 62(138):346-9. PubMed ID: 25916061
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for mortality in liver transplant recipients with ESKAPE infection.
Song SH; Li XX; Wan QQ; Ye QF
Transplant Proc; 2014 Dec; 46(10):3560-3. PubMed ID: 25498089
[TBL] [Abstract][Full Text] [Related]
5. Mortality Predictors in Acute Respiratory Distress Syndrome Renal Transplant Recipients With ESKAPE/rESKAPE Pneumonia.
Chu L; Ye QF; Wan QQ; Zhou JD
Transplant Proc; 2015 Oct; 47(8):2450-5. PubMed ID: 26518949
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
[TBL] [Abstract][Full Text] [Related]
7. Changes in the incidence and antimicrobial susceptibility of healthcare-associated infections in a New York hospital system, 2006-2012.
Cohen B; Liu J; Larson E
J Prev Med Hyg; 2017 Dec; 58(4):E294-E301. PubMed ID: 29707660
[TBL] [Abstract][Full Text] [Related]
8. Predictors of shock and mortality in solid organ transplant recipients with bacteremia caused by non-lactose-fermenting gram-negative bacilli.
Wan Q; Luo A; Ye Q; Liu S; Zhou J
Infect Dis (Lond); 2016; 48(1):32-9. PubMed ID: 26329287
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial bloodstream infections in a nationwide study: comparison between solid organ transplant patients and the general population.
Camargo LF; Marra AR; Pignatari AC; Sukiennik T; Behar PP; Medeiros EA; Ribeiro J; Girão E; Correa L; Guerra C; Brites C; Pereira CA; Carneiro I; Reis M; Souza MA; Barata CU; Edmond MB;
Transpl Infect Dis; 2015 Apr; 17(2):308-13. PubMed ID: 25726707
[TBL] [Abstract][Full Text] [Related]
10. Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis.
Leão AC; Menezes PR; Oliveira MS; Levin AS
BMC Infect Dis; 2016 Aug; 16():386. PubMed ID: 27506948
[TBL] [Abstract][Full Text] [Related]
11. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.
Diekema DJ; Hsueh PR; Mendes RE; Pfaller MA; Rolston KV; Sader HS; Jones RN
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010862
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.
Bodro M; Gudiol C; Garcia-Vidal C; Tubau F; Contra A; Boix L; Domingo-Domenech E; Calvo M; Carratalà J
Support Care Cancer; 2014 Mar; 22(3):603-10. PubMed ID: 24170166
[TBL] [Abstract][Full Text] [Related]
13. Update on the main MDR pathogens: prevalence and treatment options.
Esposito S; De Simone G
Infez Med; 2017 Dec; 25(4):301-310. PubMed ID: 29286008
[TBL] [Abstract][Full Text] [Related]
14. Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED.
Kang CI; Chung DR; Peck KR; Song JH;
Am J Emerg Med; 2012 Sep; 30(7):1169-75. PubMed ID: 22030178
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus bacteremia in solid organ transplant recipients: evidence for improved survival when compared with nontransplant patients.
Malinis MF; Mawhorter SD; Jain A; Shrestha NK; Avery RK; van Duin D
Transplantation; 2012 May; 93(10):1045-50. PubMed ID: 22357175
[TBL] [Abstract][Full Text] [Related]
16. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes.
Robenshtok E; Paul M; Leibovici L; Fraser A; Pitlik S; Ostfeld I; Samra Z; Perez S; Lev B; Weinberger M
J Hosp Infect; 2006 Nov; 64(3):282-7. PubMed ID: 16930770
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012.
Fransén J; Huss FR; Nilsson LE; Rydell U; Sjöberg F; Hanberger H
Burns; 2016 Sep; 42(6):1295-303. PubMed ID: 27241732
[TBL] [Abstract][Full Text] [Related]
18. Infection in burn patients in a referral center in Colombia.
Ramirez-Blanco CE; Ramirez-Rivero CE; Diaz-Martinez LA; Sosa-Avila LM
Burns; 2017 May; 43(3):642-653. PubMed ID: 28185802
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii.
Fu Q; Ye H; Liu S
Am J Infect Control; 2015 Aug; 43(8):857-60. PubMed ID: 25960385
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY
Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
